| Announce Date | 08/13/2025 |
| EPS Normalized Actual | $0.27 (Beat by $0.08) |
| EPS GAAP Actual | $0.27 (Beat by $0.08) |
| Revenue Actual | $0.055911B |
| Revenue Surprise | Beat by $55.911M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2028 | 0.96 | 4.06 | 0.94231 | 0.97387 | 1 |
| Jan 2028 | 0.57 | 6.84 | 0.5358 | 0.6042 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.0866 | 0.0866 | 0.055911B | -7.08% | 55.91M |
| FQ2 2025 (Apr 2025) | 0.04 | 0.04 | 0.051427B | -0.87% | 51.43M |
| FQ1 2025 (Jan 2025) | 0.0422 | 0.0422 | 0.049741B | -13.24% | 49.74M |
| FQ4 2024 (Oct 2024) | 0 | 0 | 0.05543B | 100% | 55.43M |
| FQ3 2024 (Jul 2024) | 0.0894 | 0.0894 | 0.059871B | 1.3% | 59.87M |
| FQ2 2024 (Apr 2024) | 0.058 | 0.058 | 0.051874B | 100% | 51.87M |
| FQ1 2024 (Jan 2024) | 0.0485 | 0.0485 | 0.056325B | 100% | 56.33M |
| FQ3 2023 (Jul 2023) | 0.08 | 0.08 | 0.05909B | 6.85% | 59.09M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 0.19 | -- | 0.17847 | 0.19815 | 3 |
| FQ4 2027 (Oct 2027) | 0.18 | -- | 0.16846 | 0.19142 | 2 |
| FQ3 2027 (Jul 2027) | 0.21 | -- | 0.19654 | 0.22332 | 2 |
| FQ2 2027 (Apr 2027) | 0.1 | -- | 0.09358951 | 0.10635 | 2 |
| FQ1 2027 (Jan 2027) | 0.105 | -- | 0.10107 | 0.10807 | 4 |
| FQ4 2026 (Oct 2026) | 0.0775 | -- | 0.07253187 | 0.08241743 | 4 |
| FQ3 2026 (Jul 2026) | 0.23 | 62.35 | 0.22407 | 0.23608 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 0.06B | -- | 0.05B | 0.06B | 3 |
| FQ4 2027 (Oct 2027) | 0.06B | -- | 0.06B | 0.06B | 3 |
| FQ3 2027 (Jul 2027) | 0.06B | -- | 0.06B | 0.07B | 3 |
| FQ2 2027 (Apr 2027) | 0.05B | -- | 0.05B | 0.05B | 3 |
| FQ1 2027 (Jan 2027) | 0.06B | -- | 0.05B | 0.06B | 2 |
| FQ4 2026 (Oct 2026) | 0.06B | -- | 0.05B | 0.06B | 3 |
| FQ3 2026 (Jul 2026) | 0.08B | 29.32 | 0.08B | 0.08B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.0866 | 0.0866 | 100% | |
| FQ2 2025 (Apr 2025) | 0.04 | 0.04 | 100% | |
| FQ1 2025 (Jan 2025) | 0.0422 | 0.0422 | 100% | |
| FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Jul 2024) | 0.0894 | 0.0894 | 100% | |
| FQ2 2024 (Apr 2024) | 0.058 | 0.058 | 100% | |
| FQ1 2024 (Jan 2024) | 0.0485 | 0.0485 | 100% | |
| FQ3 2023 (Jul 2023) | 0.08 | 0.08 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | $0B | $0.06B | $55.91M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $0.05B | $51.43M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $0.05B | $49.74M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.06B | $55.43M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.06B | $59.87M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.05B | $51.87M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.06B | $56.33M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $0.06B | $59.09M | 100% |